Palisade Bio (PALI) Revenue Growth (5y) (2016 - 2023)
Palisade Bio (PALI) Revenue Growth (5y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Palisade Bio | 417.21 Mn | 284.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 151.19% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 15.59% |
| Dec 31, 2019 | -11.73% |
| Sep 30, 2019 | -12.94% |
| Jun 30, 2019 | 9.56% |
| Mar 31, 2019 | -9.71% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | 151.69% |
| Mar 31, 2018 | -52.42% |
| Dec 31, 2017 | 151.69% |
| Sep 30, 2017 | -57.04% |
| Jun 30, 2017 | -49.76% |
| Mar 31, 2017 | -56.27% |
| Dec 31, 2016 | -50.26% |
| Sep 30, 2016 | -52.50% |